Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,863,093
+$24,914,242 QoQ
Shares Held
7,623,533
+29.3% QoQ
Ownership
3.47%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 257 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,554,498,511 across 303 Biotechnology names. OCUL ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in OCUL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,863,093 | 7,623,533 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,948,851 | 5,897,149 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,082,301 | 171,524 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,537,983 | 131,564 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,172,676 | 126,366 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $921,681 | 125,741 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,456,751 | 638,964 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,503,344 | 977,396 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,595,504 | 1,110,454 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,030,314 | 662,672 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $237,914 | 53,344 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $127,122 | 40,485 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $199,377 | 38,639 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $201,814 | 38,295 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $117,629 | 41,861 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $128,189 | 30,889 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $104,150 | 25,908 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $97,717 | 19,741 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $92,422 | 13,260 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $345,600 | 34,560 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $491,478 | 34,660 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $539,905 | 32,901 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $536,709 | 25,928 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||